Monitor for any future conversion of this 13G to a 13D, which would signal a shift to activist intent. The passive nature of the filing and the large asset manager profile suggest no near-term catalyst from this holder.
Price Chart
Executive Summary
Franklin Templeton Inc. filed an amended Schedule 13G disclosing beneficial ownership of 724,138 shares of Adicet Bio, Inc. common stock, representing 7.7% of shares outstanding as of September 30, 2026. This is an increase from the prior passive stake filed by Daniel Clayton Zedek and Lauren Marie Zedek on October 23, 2026 (5.4%), and from the prior filing by RA Capital Management (no stake size disclosed in the cross-filing context). The filing is a routine passive stake update by a large asset manager with no intent to influence control.
Key Financial Metrics
Key Facts
- Franklin Templeton Inc. reported beneficial ownership of 724,138 shares of Adicet Bio, Inc. common stock.
- The stake represents 7.7% of shares outstanding as of September 30, 2026.
- Franklin Advisers, Inc., a subsidiary, holds sole voting and dispositive power over all 724,138 shares.
- Franklin Biotechnology Discovery Fund, a sub-fund, has an interest in 498,920 shares (5.3% of class).
- The filing is an amendment to a Schedule 13G, indicating passive investment intent under Rule 13d-1(b).
- The filing notes that effective August 17, 2026, Franklin Resources, Inc. was renamed Franklin Templeton, Inc.
Financial Impact
Franklin Templeton holds 724,138 shares (7.7% of ACET) as of September 30, 2026. At the market cap of $37M, the stake value is approximately $2.85M.
Risk Factors
- No material risks identified from this routine passive stake amendment.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000038777-26-000272 |
| Document: 0000038777-26-000272-index.html | 0000038777-26-000272 |
| Document: 0000038777-26-000272.txt | 0000038777-26-000272 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 28, 2026 1d ago | SC 13G/A | $3.81 | awaiting T+20 | awaiting T+20 | $3.58 (−6.04%) |
Oct 23, 2026 6d ago | SC 13G | $3.94 | awaiting T+20 | awaiting T+20 | $3.58 (−9.14%) |
Sep 28, 2026 4w ago | 8-K | $6.35 $3.94 | ▼ −37.95% | ▼ −37.92% | $3.58 (−43.62%) |
Sep 1, 2026 8w ago | 8-K | $9.26 $7.12 | ▼ −23.11% | ▼ −24.29% | $3.58 (−61.34%) |
May 20, 2026 23w ago | 10-K/A | $7.89 $8.23 | ▲ +4.31% | ▲ +3.98% | $3.58 (−54.63%) |
May 13, 2026 24w ago | 8-K | $8.41 $8.05 | ▼ −4.28% | ▼ −3.42% | $3.58 (−57.43%) |
Apr 8, 2026 29w ago | 144 | $6.86 $8.55 | ▲ +24.64% | ▲ +17.07% | $3.58 (−47.81%) |
Apr 7, 2026 29w ago | 144 | $6.55 $8.51 | ▲ +29.92% | ▲ +21.38% | $3.58 (−45.34%) |
Mar 24, 2026 31w ago | EFFECT | $6.69 $8.31 | ▲ +24.22% | ▲ +15.31% | $3.58 (−46.49%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers